The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung

医药前沿nature发文：CLIP1-LTK 融合基因-非小细胞肺癌的新治疗靶点

CLIP1-LTK fusion: A novel druggable gene fusion in NSCLC

Genotype-phenotype mapping of a patient-derived lung cancer

IJMS, Free Full-Text

医药前沿nature发文：CLIP1-LTK 融合基因-非小细胞肺癌的新治疗靶点

AMG-510 and cisplatin combination increases antitumor effect in

Combinatorial tumor suppressor inactivation efficiently initiates

Utility of needle biopsy in centrally located lung cancer for

Combinatorial tumor suppressor inactivation efficiently initiates

LC-SCRUM-Asiaの遺伝子スクリーニングで肺がんの新しいドライバー

Pharos : Target Details - LTK

Tyrosine Kinase Inhibitors Target B Lymphocytes

聚焦生物医药动态（1204~1210）_西湖生物医药科技（杭州）有限公司